AIM ImmunoTech Inc. (AIM)

AIM ImmunoTech Statistics

Total Valuation

AIM ImmunoTech has a market cap or net worth of $2.95 million. The enterprise value is $4.80 million.

Market Cap	2.95M
Enterprise Value	4.80M

Important Dates

The last earnings date was Friday, March 27, 2026, before market open.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

AIM ImmunoTech has 4.22 million shares outstanding. The number of shares has increased by 188.95% in one year.

Current Share Class	4.22M
Shares Outstanding	4.22M
Shares Change (YoY)	+188.95%
Shares Change (QoQ)	+37.65%
Owned by Insiders (%)	3.77%
Owned by Institutions (%)	3.31%
Float	4.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	33.57
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	54.58
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.53

Current Ratio	0.53
Quick Ratio	0.49
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-14.36

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-101.32%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	2,638.91%
Weighted Average Cost of Capital (WACC)	12.36%
Revenue Per Employee	$3,826
Profits Per Employee	-$606,870
Employee Count	23
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -94.60% in the last 52 weeks. The beta is 1.25, so AIM ImmunoTech's price volatility has been higher than the market average.

Beta (5Y)	1.25
52-Week Price Change	-94.60%
50-Day Moving Average	0.98
200-Day Moving Average	2.90
Relative Strength Index (RSI)	40.47
Average Volume (20 Days)	9,713,412

Short Selling Information

The latest short interest is 153,264, so 3.63% of the outstanding shares have been sold short.

Short Interest	153,264
Short Previous Month	142,902
Short % of Shares Out	3.63%
Short % of Float	3.77%
Short Ratio (days to cover)	0.38

Income Statement

In the last 12 months, AIM ImmunoTech had revenue of $88,000 and -$13.96 million in losses. Loss per share was -$8.62.

Revenue	88,000
Gross Profit	-40,000
Operating Income	-11.66M
Pretax Income	-13.96M
Net Income	-13.96M
EBITDA	-11.45M
EBIT	-11.66M
Loss Per Share	-$8.62

Balance Sheet

The company has $3.05 million in cash and $4.90 million in debt, with a net cash position of -$1.85 million or -$0.44 per share.

Cash & Cash Equivalents	3.05M
Total Debt	4.90M
Net Cash	-1.85M
Net Cash Per Share	-$0.44
Equity (Book Value)	-9.78M
Book Value Per Share	-3.19
Working Capital	-2.93M

Cash Flow

Operating Cash Flow	-10.96M
Capital Expenditures	n/a
Depreciation & Amortization	210,000
Net Borrowing	2.09M
Free Cash Flow	-10.96M
FCF Per Share	-$2.60

Margins

Gross Margin	-45.45%
Operating Margin	-13,254.55%
Pretax Margin	-15,861.36%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AIM ImmunoTech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-188.95%
Shareholder Yield	-188.95%
Earnings Yield	-472.45%
FCF Yield	-370.88%

Analyst Forecast

The average price target for AIM ImmunoTech is $21.98, which is 3,040.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.98
Price Target Difference	3,040.00%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	129.07%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 9, 2026. It was a forward split with a ratio of 1.001:1.

Last Split Date	Jan 9, 2026
Split Type	Forward
Split Ratio	1.001:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1